BioVoice News September 2017 Issue 4 Volume 2 | Page 34

bio chat Patients have been delighted that they were able to get the undivided attention from our doctors for over 20 minutes and with our follow up standing medical problems. Apart from managing acute and chronic patients, we have helped to diagnose cases like hemochromatosis (iron overload), gastric cancer, triple vessel disease, nephrology, Parkinson-plus and more. This has made possible due to the detailed medical protocols, quality time 34 BioVoiceNews | September 2017 and our end-to-end ecosystem of diagnosis and specialist referrals. Does the health consultation system actually work in India where a huge population in rural areas are still grappling with basic healthcare issues? What is IHO doing in that area? In a global mHealth adoption study conducted by PwC in 2012, India was ranked 2nd among the developing countries in terms of maturity. The study established that consumers in developing countries like India have high expectations for digital healthcare and 60 percent of the consumers strongly believe that mhealth will improve the convenience, cost, and quality of their healthcare. There is a widespread access to mobile/telephone that can enable people to access quality medical services on phone and get proper treatment and advice. It is true that the rural population is likely to benefit from our vHealth service. The challenge is distribution and reach. We are working with our network partners to solve this problem and deliver vHealth to rural India at a reasonable cost. Watch this space as this is still work in progress. Please tell us about the latest activities at Indian Health Organization? What are the top areas of priority for the organization? We at Indian Health Organisation are focused on making quality health care accessible in India. With this objective,